These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 10348313)

  • 1. A proton magnetic resonance spectroscopy study of the striatum and cerebral cortex in Parkinson's disease.
    Taylor-Robinson SD; Turjanski N; Bhattacharya S; Seery JP; Sargentoni J; Brooks DJ; Bryant DJ; Cox IJ
    Metab Brain Dis; 1999 Mar; 14(1):45-55. PubMed ID: 10348313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parkinson's disease: in vivo metabolic changes in the frontal and parietal cortices in 6-OHDA treated rats during different periods.
    Hou Z; Zhang Z; Meng H; Lin X; Sun B; Lei H; Fang K; Fang F; Liu M; Liu S
    Int J Neurosci; 2014 Feb; 124(2):125-32. PubMed ID: 23931110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proton magnetic resonance spectroscopy in Huntington's disease: evidence in favour of the glutamate excitotoxic theory.
    Taylor-Robinson SD; Weeks RA; Bryant DJ; Sargentoni J; Marcus CD; Harding AE; Brooks DJ
    Mov Disord; 1996 Mar; 11(2):167-73. PubMed ID: 8684387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in putamen N-acetylaspartate and choline ratios in untreated and levodopa-treated Parkinson's disease: a proton magnetic resonance spectroscopy study.
    Ellis CM; Lemmens G; Williams SC; Simmons A; Dawson J; Leigh PN; Chaudhuri KR
    Neurology; 1997 Aug; 49(2):438-44. PubMed ID: 9270574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebral diffusion tensor imaging and in vivo proton magnetic resonance spectroscopy in patients with fulminant hepatic failure.
    Saksena S; Rai V; Saraswat VA; Rathore RS; Purwar A; Kumar M; Thomas MA; Gupta RK
    J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e111-9. PubMed ID: 17924951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proton MR spectroscopic imaging of the striatum in Parkinson's disease.
    Cruz CJ; Aminoff MJ; Meyerhoff DJ; Graham SH; Weiner MW
    Magn Reson Imaging; 1997; 15(6):619-24. PubMed ID: 9285801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glutamate measurement in Parkinson's disease using MRS at 3 T field strength.
    Kickler N; Krack P; Fraix V; Lebas JF; Lamalle L; Durif F; Krainik A; Rémy C; Segebarth C; Pollak P
    NMR Biomed; 2007 Dec; 20(8):757-62. PubMed ID: 17334978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MRS study on lentiform nucleus in idiopathic Parkinson's disease with unilateral symptoms.
    Zheng XN; Zhu XC; Ruan LX; Zhang LJ; Yuan M; Shang DS; Liu Y
    J Zhejiang Univ Sci; 2004 Feb; 5(2):246-50. PubMed ID: 14674041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unchanged basal ganglia N-acetylaspartate and glutamate in idiopathic Parkinson's disease measured by proton magnetic resonance spectroscopy.
    Clarke CE; Lowry M; Horsman A
    Mov Disord; 1997 May; 12(3):297-301. PubMed ID: 9159722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proton magnetic resonance spectroscopy in Parkinson's disease and progressive supranuclear palsy.
    Federico F; Simone IL; Lucivero V; De Mari M; Giannini P; Iliceto G; Mezzapesa DM; Lamberti P
    J Neurol Neurosurg Psychiatry; 1997 Mar; 62(3):239-42. PubMed ID: 9069478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic Alterations Within the Primary Visual Cortex in Early Open-angle Glaucoma Patients: A Proton Magnetic Resonance Spectroscopy Study.
    Guo L; Wang R; Tang Z; Sun X; Wu L; Wang J; Zhong Y; Xiao Z; Zhang Z
    J Glaucoma; 2018 Dec; 27(12):1046-1051. PubMed ID: 30256276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Striatal neuronal loss or dysfunction and choline rise in children with attention-deficit hyperactivity disorder: a 1H-magnetic resonance spectroscopy study.
    Jin Z; Zang YF; Zeng YW; Zhang L; Wang YF
    Neurosci Lett; 2001 Nov; 315(1-2):45-8. PubMed ID: 11711211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Basal ganglia metabolite concentrations in idiopathic Parkinson's disease and multiple system atrophy measured by proton magnetic resonance spectroscopy.
    Clarke CE; Lowry M
    Eur J Neurol; 2000 Nov; 7(6):661-5. PubMed ID: 11136352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Valproate-induced metabolic changes in patients with epilepsy: assessment with H-MRS.
    Garcia M; Huppertz HJ; Ziyeh S; Buechert M; Schumacher M; Mader I
    Epilepsia; 2009 Mar; 50(3):486-92. PubMed ID: 19183221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myoinositol and glutamate complex neurometabolite abnormality after mild traumatic brain injury.
    Kierans AS; Kirov II; Gonen O; Haemer G; Nisenbaum E; Babb JS; Grossman RI; Lui YW
    Neurology; 2014 Feb; 82(6):521-8. PubMed ID: 24401686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proton magnetic resonance spectroscopic imaging in progressive supranuclear palsy, Parkinson's disease and corticobasal degeneration.
    Tedeschi G; Litvan I; Bonavita S; Bertolino A; Lundbom N; Patronas NJ; Hallett M
    Brain; 1997 Sep; 120 ( Pt 9)():1541-52. PubMed ID: 9313638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proton magnetic resonance imaging and spectroscopy identify metabolic changes in the striatum in the MPTP feline model of parkinsonism.
    Podell M; Hadjiconstantinou M; Smith MA; Neff NH
    Exp Neurol; 2003 Feb; 179(2):159-66. PubMed ID: 12618122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Positive correlations between cerebral choline and renal dysfunction in chronic renal failure.
    Sasaki O; Hattori N; Nakahama H; Inoue N; Nakamura S; Inenaga T; Kohno S; Sawada T; Kawano Y
    Neuroradiology; 2006 May; 48(5):300-6. PubMed ID: 16586119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amino acid metabolic processes in the temporal lobes assessed by proton magnetic resonance spectroscopy (1H MRS) in children with Down syndrome.
    Śmigielska-Kuzia J; Boćkowski L; Sobaniec W; Kułak W; Sendrowski K
    Pharmacol Rep; 2010; 62(6):1070-7. PubMed ID: 21273664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proton MRS in acute traumatic brain injury: role for glutamate/glutamine and choline for outcome prediction.
    Shutter L; Tong KA; Holshouser BA
    J Neurotrauma; 2004 Dec; 21(12):1693-705. PubMed ID: 15684761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.